Skip to main content

Table 3 Cost-effectiveness of rotavirus vaccine, (lower limit, upper limit)

From: Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study

Incremental cost-effectiveness ratio (US$)

RI value

SIA value

Cost per DALY averted

5.30 (1.35-14.28)

37.62 (12.86-74.93)

Cost per case averted

2.81 (0.58-6.15)

16.20 (5.54-21.54)

Cost per death averted

270.56 (68.85-729.62)

1,921.52 (656.90-2,553.83)